SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-19-004618
Filing Date
2019-06-25
Accepted
2019-06-25 16:33:19
Documents
2
Period of Report
2019-07-24
Effectiveness Date
2019-06-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT admp-def14a_072419.htm DEF 14A 1365544
2 GRAPHIC admp-def14a_img001.jpg GRAPHIC 11219
  Complete submission text file 0001387131-19-004618.txt   1382312
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36242 | Film No.: 19918921
SIC: 2834 Pharmaceutical Preparations